Aurobindo Pharma (AUROPHARMA) — Announcement

1 Announcement 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Aurobindo Pharma receives USFDA final approval for Beclomethasone Dipropionate HFA inhaler

🔮 What's Next
upcoming quarters

💡 Investor Takeaway
This approval opens a new high-growth respiratory market segment for Aurobindo Pharma.

Aurobindo Pharma announced USFDA final approval for its first metered-dose inhaler, Beclomethasone Dipropionate HFA aerosol in 40 mcg and 80 mcg strengths, marking entry into complex respiratory therapies. The product targets a $301 million US market and will launch in upcoming quarters from its North Carolina facility. This expands the company's USFDA-approved portfolio to 596 products, including 571 final approvals.

2 Announcement 🔴 High Importance Neutral 📄 PDF

📢 Key Event
US FDA inspection completed at Apitoria Pharma's Unit-II facility with one procedural observation.

💡 Investor Takeaway
The company maintains strong compliance standards and will promptly address the FDA observation without immediate financial or operational disruption.

Aurobindo Pharma announced the completion of a US FDA inspection at its Apitoria Pharma subsidiary's Unit-II facility in Telangana, which concluded with one procedural observation that the company will address within the stipulated timeline, reaffirming its commitment to quality standards and pledging to update exchanges on any further developments.

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Ltd (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹94,419.51 Cr P/E: 25.6 ROE: 9.8% ROCE: 12.8% Div Yield: 0.24%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"When will Beclomethasone HFA launch in the US market?" "What is the revenue contribution target for the new inhaler product?" "How does this approval affect Aurobindo's valuation multiples?"

Ask AI Free →

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

🔥 Also filed on 15 September 2026

MUTHOOTMF Muthoot Microfin Ltd Corporate Action JUBLFOOD Jubilant Foodworks Ltd Announcement 523467 Jai Mata Glass Ltd Offer Document BLUECLOUDS Blue Cloud Softech Solutions Ltd Announcement FREDUN Fredun Pharmaceuticals Ltd Announcement IZMO IZMO Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AUROPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Aurobindo Pharma Ltd (AUROPHARMA) — Announcement | 15 September 2026(2 announcements)

About Aurobindo Pharma Ltd (AUROPHARMA)

📡 Get AI alerts when AUROPHARMA files next

💡 Ask AI about this filing

📊 More AUROPHARMA filings

🔥 Also filed on 15 September 2026